FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344100512> ?p ?o ?g. }

• W2344100512 endingPage "1402" @default.
• W2344100512 startingPage "1398" @default.
• W2344100512 abstract "BACKGROUND:Chronic hepatitis C virus (HCV) infection leads to life-threatening complications worldwide. Immunomodulation signals the response to virus clearance. The immune-suppressive molecule human leukocyte antigen-G (HLA-G) has been shown to function in inhibiting both innate and adaptive immune responses. The objective of this study was to investigate the expression of HLA-G and IL-37 in sustained virological response (SVR) and non-SVR HCV-positive patients before and after complete treatment with a combination of pegylated interferon (IFN) and ribavirin (RBV). MATERIAL AND METHODS:Our study included 132 chronic hepatitis C patents who received combined therapy with IFN-a and RBV. Both SVR and non-SVR patients were included. The end-of-treatment response was defined as undetectable HCV RNA at week 48. Patients with end-of-treatment response were detected by HCV RNA at 24 weeks after therapy. The expression levels of HLA-G and IL-37 at the end and 24 weeks after treatment were detected by ELISA. RESULTS:Plasma HLA-G and IL-37 were significantly increased in HCV-infected patients compared with healthy individuals before treatment. Furthermore, HLA-G in SVR patients was noticeably decreased after treatment, while HLA-G in non-SVR patients had no changes after treatment. Additionally, both in SVR and non-SVR patients, the expression of IL-37 was remarkably reduced compared with baseline after treatment. CONCLUSIONS:These findings suggest that elevation of HLA-G and IL-37 in HCV may play an important role in response to combined therapy with IFN-a and RBV. Monitoring the expression of HLA-G during therapy could contribute to adjusting the treatment program of HCV-infected patients." @default.
• W2344100512 created "2016-06-24" @default.
• W2344100512 creator A5021404672 @default.
• W2344100512 creator A5029277359 @default.
• W2344100512 creator A5043337963 @default.
• W2344100512 creator A5044877715 @default.
• W2344100512 creator A5050616783 @default.
• W2344100512 creator A5066998474 @default.
• W2344100512 date "2016-04-26" @default.
• W2344100512 modified "2023-10-01" @default.
• W2344100512 title "Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37" @default.
• W2344100512 cites W1562804387 @default.
• W2344100512 cites W1942926563 @default.
• W2344100512 cites W1974777107 @default.
• W2344100512 cites W1975254368 @default.
• W2344100512 cites W1979174109 @default.
• W2344100512 cites W1979253523 @default.
• W2344100512 cites W1988458895 @default.
• W2344100512 cites W1989173653 @default.
• W2344100512 cites W1991106514 @default.
• W2344100512 cites W1993057196 @default.
• W2344100512 cites W2007503469 @default.
• W2344100512 cites W2013068598 @default.
• W2344100512 cites W2013433867 @default.
• W2344100512 cites W2029323175 @default.
• W2344100512 cites W2046788012 @default.
• W2344100512 cites W2047056707 @default.
• W2344100512 cites W2048498762 @default.
• W2344100512 cites W2049003089 @default.
• W2344100512 cites W2064546869 @default.
• W2344100512 cites W2086423366 @default.
• W2344100512 cites W2086705711 @default.
• W2344100512 cites W2091547143 @default.
• W2344100512 cites W2113864802 @default.
• W2344100512 cites W2130443831 @default.
• W2344100512 cites W2144421609 @default.
• W2344100512 cites W2161684908 @default.
• W2344100512 cites W2323850699 @default.
• W2344100512 cites W2462192596 @default.
• W2344100512 doi "https://doi.org/10.12659/msm.895971" @default.
• W2344100512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4915332" @default.
• W2344100512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27112970" @default.
• W2344100512 hasPublicationYear "2016" @default.
• W2344100512 type Work @default.
• W2344100512 sameAs 2344100512 @default.
• W2344100512 citedByCount "5" @default.
• W2344100512 countsByYear W23441005122016 @default.
• W2344100512 countsByYear W23441005122019 @default.
• W2344100512 countsByYear W23441005122021 @default.
• W2344100512 countsByYear W23441005122022 @default.
• W2344100512 countsByYear W23441005122023 @default.
• W2344100512 crossrefType "journal-article" @default.
• W2344100512 hasAuthorship W2344100512A5021404672 @default.
• W2344100512 hasAuthorship W2344100512A5029277359 @default.
• W2344100512 hasAuthorship W2344100512A5043337963 @default.
• W2344100512 hasAuthorship W2344100512A5044877715 @default.
• W2344100512 hasAuthorship W2344100512A5050616783 @default.
• W2344100512 hasAuthorship W2344100512A5066998474 @default.
• W2344100512 hasBestOaLocation W23441005122 @default.
• W2344100512 hasConcept C126322002 @default.
• W2344100512 hasConcept C147483822 @default.
• W2344100512 hasConcept C188280979 @default.
• W2344100512 hasConcept C203014093 @default.
• W2344100512 hasConcept C2522874641 @default.
• W2344100512 hasConcept C2776178377 @default.
• W2344100512 hasConcept C2776408679 @default.
• W2344100512 hasConcept C2776455275 @default.
• W2344100512 hasConcept C2776461080 @default.
• W2344100512 hasConcept C2776999253 @default.
• W2344100512 hasConcept C2780040827 @default.
• W2344100512 hasConcept C2781463415 @default.
• W2344100512 hasConcept C71924100 @default.
• W2344100512 hasConcept C8891405 @default.
• W2344100512 hasConcept C90924648 @default.
• W2344100512 hasConceptScore W2344100512C126322002 @default.
• W2344100512 hasConceptScore W2344100512C147483822 @default.
• W2344100512 hasConceptScore W2344100512C188280979 @default.
• W2344100512 hasConceptScore W2344100512C203014093 @default.
• W2344100512 hasConceptScore W2344100512C2522874641 @default.
• W2344100512 hasConceptScore W2344100512C2776178377 @default.
• W2344100512 hasConceptScore W2344100512C2776408679 @default.
• W2344100512 hasConceptScore W2344100512C2776455275 @default.
• W2344100512 hasConceptScore W2344100512C2776461080 @default.
• W2344100512 hasConceptScore W2344100512C2776999253 @default.
• W2344100512 hasConceptScore W2344100512C2780040827 @default.
• W2344100512 hasConceptScore W2344100512C2781463415 @default.
• W2344100512 hasConceptScore W2344100512C71924100 @default.
• W2344100512 hasConceptScore W2344100512C8891405 @default.
• W2344100512 hasConceptScore W2344100512C90924648 @default.
• W2344100512 hasLocation W23441005121 @default.
• W2344100512 hasLocation W23441005122 @default.
• W2344100512 hasLocation W23441005123 @default.
• W2344100512 hasLocation W23441005124 @default.
• W2344100512 hasOpenAccess W2344100512 @default.
• W2344100512 hasPrimaryLocation W23441005121 @default.
• W2344100512 hasRelatedWork W1586448152 @default.
• W2344100512 hasRelatedWork W1911438026 @default.
• W2344100512 hasRelatedWork W1991118604 @default.

• next